Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Role of (Endo)Cannabinoids in Migraine
Pinja Leimuranta, Leonard Khiroug, Rashid Giniatullin
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 204
Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research
Eleonóra Spekker, Masaru Tanaka, Ágnes Szabó, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 76-76
Open Access | Times Cited: 117
Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice
Erik Zorrilla, Georgii Krivoshein, Adisa Kuburas, et al.
Cephalalgia (2025) Vol. 45, Iss. 2
Closed Access | Times Cited: 1
Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
Mohammad Zakir Hossain, Hiroshi Ando, Shumpei Unno, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1423-1423
Open Access | Times Cited: 47
Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence
Babasola O. Okusanya, Breanne E. Lott, John Ehiri, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 26
Effects of the Dual FAAH/MAGL Inhibitor AKU-005 on Trigeminal Hyperalgesia in Male Rats
Rosaria Greco, Chiara Demartini, Miriam Francavilla, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 830-830
Open Access | Times Cited: 5
Migraine Aura: Pathophysiology, Mimics, and Treatment Options
Clare L. Fraser, Jenny L. Hepschke, Bronwyn Jenkins, et al.
Seminars in Neurology (2019) Vol. 39, Iss. 06, pp. 739-748
Closed Access | Times Cited: 41
Phytomedicines in the Treatment of Migraine
Thilinie Rajapakse, William Jeptha Davenport
CNS Drugs (2019) Vol. 33, Iss. 5, pp. 399-415
Closed Access | Times Cited: 40
Crosstalk Between the Gut Microbiome and Bioactive Lipids: Therapeutic Targets in Cognitive Frailty
Liliana C. Baptista, Yi Sun, Christy S. Carter, et al.
Frontiers in Nutrition (2020) Vol. 7
Open Access | Times Cited: 34
5‐hydroxytryptamine in migraine: The puzzling role of ionotropic 5‐HT3 receptor in the context of established therapeutic effect of metabotropic 5‐HT1 subtypes
Rashid Giniatullin
British Journal of Pharmacology (2021) Vol. 179, Iss. 3, pp. 400-415
Open Access | Times Cited: 28
Interplay between cannabinoids and the neuroimmune system in migraine
Erik Zorrilla, Adriana Della Pietra, Andrew F. Russo
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Inhibition of endocannabinoid hydrolases MAGL, FAAH and ABHD6 by AKU-005 reduces ex vivo cortical spreading depression
Flavia Brugia, Konstantin Ivanov, Auni Aroviita, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Targeting the endocannabinoid system with microbial interventions to improve gut integrity
Jack Jansma, Fleur Brinkman, Saskia van Hemert, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110169-110169
Open Access | Times Cited: 31
Receptor mechanisms mediating the anti‐neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine
Erkan Kılınç, Seyit Ankaralı, İbrahim Ethem Torun, et al.
European Journal of Neuroscience (2020) Vol. 55, Iss. 4, pp. 1015-1031
Closed Access | Times Cited: 29
Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine
Adriana Della Pietra, Rashid Giniatullin, Juha R. Savinainen
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1204-1204
Open Access | Times Cited: 27
The endocannabinoid system and related lipids as potential targets for the treatment of migraine‐related pain
Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, et al.
Headache The Journal of Head and Face Pain (2022) Vol. 62, Iss. 3, pp. 227-240
Closed Access | Times Cited: 18
Clinical Evidence of Cannabinoids in Migraine: A Narrative Review
Flavia Lo Castro, Carlo Baraldi, Lanfranco Pellesi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1479-1479
Open Access | Times Cited: 17
ABHD6 and MAGL control 2-AG levels in the PAG and allodynia in a CSD-induced periorbital model of headache
Erika Liktor‐Busa, Aidan Levine, Seph M. Palomino, et al.
Frontiers in Pain Research (2023) Vol. 4
Open Access | Times Cited: 10
The Pharmacology of Cannabinoids in Chronic Pain
Alonso Cortez-Resendiz, Timothy J Leiter, S. Riela, et al.
Medical Cannabis and Cannabinoids (2025)
Open Access
Enhancement of the endocannabinoid system through monoacylglycerol lipase inhibition relieves migraine-associated pain in mice
Elizaveta Mangutov, Yaseen Awad-Igbaria, Kendra Siegersma, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain
Adriana Della Pietra, Georgii Krivoshein, Konstantin Ivanov, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Preclinical effects of cannabidiol in an experimental model of migraine
Chiara Sturaro, Bianca Fakhoury, Katarzyna M. Targowska‐Duda, et al.
Pain (2023) Vol. 164, Iss. 11, pp. 2540-2552
Open Access | Times Cited: 8
Substance use in a Dutch migraine cohort compared with the general population
Thomas C. van den Hoek, Iris E. Verhagen, Irene de Boer, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 2, pp. 141-148
Open Access | Times Cited: 3
Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain
Adriana Della Pietra, Juha R. Savinainen, Rashid Giniatullin
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4407-4407
Open Access | Times Cited: 13
New discoveries in migraine mechanisms and therapeutic targets
Gregory Dussor
Current Opinion in Physiology (2019) Vol. 11, pp. 116-124
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top